Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Turpin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Oncogene|April 4, 2017
Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanomaA Jain, R Tripathi, C P Turpin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|July 29, 2015
Spatial transformation-enabled electromagnetic devices: from radio frequencies to optical wavelengthsZhi Hao Jiang, Jeremy P Turpin, Kennith Morgan, et al.
Postgraduate Medical Journal|May 14, 2003
Oral vitamin B12 can change our practiceE Nyholm, P Turpin, D Swain, et al.
Journal of Receptor and Signal Transduction Research|July 4, 1998
Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus systemK Lundstrom, M P Turpin, C Large, et al.
Behavioural Brain Research|October 31, 1992
Modulation of the rat mesolimbic dopamine pathway by neurokininsP J Elliott, G S Mason, E A Graham, et al.
Optics Express|February 23, 2010
Conformal mappings to achieve simple material parameters for transformation optics devicesJeremiah P Turpin, Ayah T Massoud, Zhi Hao Jiang, et al.
Journal of Cell Science|February 1, 1997
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasmF Arenzana-Seisdedos, P Turpin, M Rodriguez, et al.
European Journal of Pharmacology|December 21, 1993
Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark boxS C Stratton, I J Beresford, F J Harvey, et al.
European Journal of Pharmacology|January 16, 1995
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oncogene|April 4, 2017
Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanomaA Jain, R Tripathi, C P Turpin, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|July 29, 2015
Spatial transformation-enabled electromagnetic devices: from radio frequencies to optical wavelengthsZhi Hao Jiang, Jeremy P Turpin, Kennith Morgan, et al.
Postgraduate Medical Journal|May 14, 2003
Oral vitamin B12 can change our practiceE Nyholm, P Turpin, D Swain, et al.
Journal of Receptor and Signal Transduction Research|July 4, 1998
Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus systemK Lundstrom, M P Turpin, C Large, et al.
Behavioural Brain Research|October 31, 1992
Modulation of the rat mesolimbic dopamine pathway by neurokininsP J Elliott, G S Mason, E A Graham, et al.
Optics Express|February 23, 2010
Conformal mappings to achieve simple material parameters for transformation optics devicesJeremiah P Turpin, Ayah T Massoud, Zhi Hao Jiang, et al.
Journal of Cell Science|February 1, 1997
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasmF Arenzana-Seisdedos, P Turpin, M Rodriguez, et al.
European Journal of Pharmacology|December 21, 1993
Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark boxS C Stratton, I J Beresford, F J Harvey, et al.
European Journal of Pharmacology|January 16, 1995
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.
Pageof 2